Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing ...

Overview of Diagnostic Biomarkers MarketThe Global Diagnostic Biomarkers Market is valued at USD 98.82 Billion in 2024 and is ...

The proteomics outsourcing market is experiencing rapid expansion, projected to grow from USD 3.3 billion in 2025 to USD 9.3 billion by 2035, reflecting a CAGR of 10.7%. Get Sample Report: – ...

In recent years, the analysis of single-cell and spatial data has revolutionized biomedical research, making it possible to ...

It is tempting to trace the origins of bioinformatics to the recent convergence of DNA sequencing, large-scale genome projects, the internet and supercomputers 1, 2, 3. However, some scientists ...

Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...

Explore how multiomics research combines genomics, proteomics, and transcriptomics to offer new insights in disease modeling ...

With an aim to bring new tools to advance regenerative agriculture, these companies see microbiome soil tests as complements to traditional soil testing.

The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...

Characterization of intracellular synapse heterogeneity aides to understand the intricate computational logic of neuronal circuits. Despite recent advances in connectomics, the spatial patterns of ...

Monoclonal antibodies are fundamental to modern biomedical research, therapeutic development, and diagnostic applications.